SSKN — STRATA Skin Sciences Income Statement
0.000.00%
- $12.73m
- $22.57m
- $33.36m
- 28
- 63
- 17
- 29
Annual income statement for STRATA Skin Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.6 | 23.1 | 30 | 36.2 | 33.4 |
Cost of Revenue | |||||
Gross Profit | 20.3 | 14.1 | 19.9 | 21.8 | 18.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35 | 27.2 | 32.4 | 40.8 | 42.9 |
Operating Profit | -3.42 | -4.08 | -2.37 | -4.65 | -9.51 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.94 | -4.14 | -2.67 | -5.49 | -10.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.79 | -4.41 | -2.71 | -5.55 | -10.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.79 | -4.41 | -2.71 | -5.55 | -10.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.79 | -4.41 | -2.71 | -5.55 | -10.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.1 | -1.31 | -1.21 | -1.59 | -2.49 |